Morgan Stanley
-
-
-
-
-
-
-
REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants
-
-
-
-
-
-
-
Regenxbio Inc. (RGNX) Key Points to Abbvie Deal - Morgan Stanley
-
-
-
-
-
-
-
Regenxbio (RGNX) Announces Proposed $175M Public Offering Of Common Stock
-
-
-
-
-
-
-
Regenxbio Inc. (RGNX) PT Raised to $85 at Morgan Stanley
-
-
-
-
-
-
-
Regenxbio (RGNX) Plans $175M Public Offering Of Common Stock
-
-
-
-
-
-
-
REGENXBIO to Present at Upcoming Investor Conferences
-
-
-
-
-
-
-
Regenxbio (RGNX) Plans $75M Common Stock Offering
-
211,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

